SHOWW

The New England Journal of Medicine has published the following articles:

<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" rel="nofollow noopener noreferrer" target="_blank">Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM</a>

<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" rel="nofollow noopener noreferrer" target="_blank">Tirzepatide Once Weekly for the Treatment of Obesity | NEJM</a>

<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563?query=featured_home" rel="nofollow noopener noreferrer" target="_blank">Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes | NEJM</a>

- <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" rel="nofollow noopener noreferrer" target="_blank">Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM</a>
- <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" rel="nofollow noopener noreferrer" target="_blank">Tirzepatide Once Weekly for the Treatment of Obesity | NEJM</a>
- <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563?query=featured_home" rel="nofollow noopener noreferrer" target="_blank">Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes | NEJM</a>

Where can I find clinical trial information on Semaglutide and Tirzepatide?

Find answers and get help from Intercom Support and Community Experts

Empty Help Center

Uh oh. That page doesn’t exist.

Disappointed

Neutral

Smiley

Title

Track the progress of all tickets related to your company.

Tickets portal.

{assigneeName} needs more information from you